Skip to content

Electronic Prior Authorization Testing Reshapes Provider-Payer Competition Before Market Deployment

1nessAgency 9 min read

Listen to this article

0:00
✦ Takeaways by 1ness AI
  • The ONC and CMS opened registration for 10-12 week electronic prior authorization testing sprints with a November 20 deadline for the first round, recruiting payers, providers, EHR developers, and intermediaries to test systems in a virtual environment called FHIRplace.
  • Testing will use HL7 FHIR Da Vinci implementation guides for Coverage Requirements Discovery, Documentation Templates and Rules, and Prior Authorization Support, with MITRE leading coordination and Drummond Group operating the FHIRplace environment.
  • Organizations participating in testing gain competitive intelligence about how trading partners (payers, EHR vendors, and intermediaries) are implementing electronic prior authorization before broader market deployment.
  • Prior authorization delays currently cause patients to abandon care plans and switch providers, making electronic authorization a critical market share driver for organizations that prepare before widespread deployment.

The federal government just opened registration for collaborative testing of electronic prior authorization systems, marking the shift from policy mandate to operational reality. The Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services (CMS) announced they are recruiting payers, providers, EHR developers, and intermediaries for 10–12-week testing sprints focused on identifying workflow gaps before widespread deployment . For healthcare marketers, this represents a critical inflection point: the administrative friction that drives patient abandonment and referral leakage is about to change fundamentally, and organizations that prepare now will capture market share from those caught flat-footed.

The initiative brings trading partners together to test real-world scenarios using HL7 FHIR Da Vinci implementation guides for Coverage Requirements Discovery, Documentation Templates and Rules, and Prior Authorization Support . Testing will occur in a virtual environment called FHIRplace, operated by Drummond Group, with the MITRE-led Health Federally Funded Research and Development Center coordinating participant matching and readiness discussions . Organizations have until November 20 to express interest in the first round, with additional testing opportunities planned .

Susan Hull at MITRE serves as the contact point for organizations interested in participating . ONC and CMS emphasized that participation is voluntary and does not constitute certification under the ONC Health IT Certification Program or determine compliance with CMS requirements .

The timing matters because regulations and industry standards have established the framework for electronic prior authorization, but production implementation exposes the technical barriers and workflow gaps that undermine patient experience . When prior authorization delays treatment, patients abandon care plans, switch providers, or select competitors with smoother access pathways. The testing sprints aim to surface these friction points while organizations can still address them, rather than discovering breakdowns after patients have already left your system.

The Patient Experience Gap Electronic Prior Authorization Creates

Prior authorization represents one of healthcare's most consequential patient experience failures. Every handoff between provider systems and payer systems introduces delay, confusion, and opportunities for patients to disengage . Patients do not distinguish between administrative problems and clinical incompetence: they experience the delay as a failure of your organization to deliver timely care.

The ONC-CMS testing initiative focuses on high-volume clinical services that require prior authorization, examining how requests and decisions move across connected systems . This matters for marketing strategy because these high-volume services (imaging studies, specialist referrals, specialty pharmacy, durable medical equipment) often represent the gateway to deeper patient relationships and higher lifetime value. When authorization delays cause patients to seek care elsewhere, you lose not just the immediate procedure but the downstream revenue stream.

Organizations participating in testing will use production-like environments to examine end-to-end workflows, identifying technical barriers before broader deployment . The scenarios are designed to replicate real conditions, meaning participants will discover exactly where their systems fail patients before those failures damage market position.

Competitor Intelligence Embedded in Testing Participation

The testing initiative creates an intelligence asymmetry between participants and non-participants. Organizations that join the sprints gain visibility into how their trading partners (payers, EHR vendors, intermediaries) are implementing electronic prior authorization. They see which payers are prepared, which EHR systems are ready, and where workflow gaps create competitive vulnerability.

For health systems competing on access and convenience, this intelligence translates directly to market advantage. If your primary competitor participates in testing and you do not, they will identify and fix authorization bottlenecks that continue to plague your patient acquisition funnel. When their patients receive authorization in hours rather than days, your brand promise of patient-centered care rings hollow.

ONC and CMS encouraged participation from organizations of all sizes, including smaller organizations and those serving rural communities . This represents unusual attention to market diversity in federal testing initiatives. Small and rural providers often face the steepest administrative burden from prior authorization, precisely because they lack the IT infrastructure and dedicated staff to navigate complex workflows. The testing initiative levels the field, allowing smaller organizations to identify problems and advocate for solutions alongside major health systems and national payers.

Marketing Operations Changes Electronic Prior Authorization Demands

Electronic prior authorization fundamentally changes the data healthcare marketers can access and the interventions they can deploy. When authorization workflows move from phone calls and fax machines to FHIR-enabled API exchanges, every step generates structured data about where patients encounter friction.

Marketers can analyze authorization approval rates by service line, identify payers with the longest processing times, and measure the conversion rate from authorization request to completed appointment. This operational transparency transforms prior authorization from an invisible administrative process to a measurable component of patient acquisition cost.

More importantly, electronic workflows enable automated patient communication at each authorization stage. Rather than leaving patients in informational limbo between requesting a service and receiving approval, marketers can deploy triggered messaging that explains process status, sets expectations for timeline, and provides alternative options if authorization is denied. These interventions reduce abandonment and signal operational competence that differentiates your organization from competitors still operating manual workflows.

The testing scenarios use Coverage Requirements Discovery, which allows provider systems to query payer requirements in real-time during clinical workflows . For marketing operations, this capability means front-desk staff and call center representatives can provide patients with accurate information about coverage and authorization requirements at the point of scheduling, rather than discovering problems days later. This eliminates the patient frustration cycle that begins with scheduling optimism and ends with authorization disappointment, a cycle that drives negative reviews and referral pattern changes.

Follow the Money: Prior Authorization Economics and Market Share

Prior authorization imposes direct costs on providers through staff time and indirect costs through delayed or foregone revenue. When authorization takes days or weeks, procedures are postponed, patients seek care elsewhere, and providers carry unfilled capacity. Electronic workflows compress authorization timelines, reducing both direct administrative costs and opportunity costs from delayed care.

For payers, electronic prior authorization reduces manual review burden and creates data streams for utilization management. The economic incentives align: both providers and payers benefit from faster, more efficient authorization processes. This alignment creates marketing opportunity for organizations that can demonstrate operational excellence in authorization workflows.

Health systems that participate in the testing initiative position themselves to negotiate more favorable contract terms with payers by demonstrating readiness for electronic workflows. Payers seeking to reduce their own administrative costs will direct volume toward providers with smooth authorization integration. This network steering effect compounds over time, as payers build preferred provider relationships around operational capabilities rather than purely clinical metrics.

Compliance Context: Voluntary Testing, Mandatory Implementation

The ONC-CMS initiative is voluntary, but the regulatory momentum behind electronic prior authorization is not . CMS has established requirements for payers to support prior authorization APIs, and provider organizations face increasing pressure to adopt interoperable systems. The testing sprints offer a low-stakes environment to identify compliance gaps before mandatory deadlines create operational crises.

For marketing leaders, the compliance timeline creates urgency around operational readiness. Promoting convenient access and patient-centered care becomes untenable when your authorization workflows generate week-long delays and force patients to navigate bureaucratic mazes. The gap between marketing promise and operational reality drives patient dissatisfaction and brand damage.

Organizations that wait for mandatory compliance deadlines to address authorization workflows will discover problems when patients are already experiencing failures. Testing participation allows you to surface and fix issues while they remain internal operational problems, before they become public patient experience failures that damage market reputation.

The 1ness Take

Healthcare marketing has treated prior authorization as someone else's problem, an operational issue, a revenue cycle concern, a necessary evil that marketing must work around. This testing initiative makes clear that prior authorization is now a marketing differentiator. The health systems that invest in electronic authorization workflows today will own the "no-hassle access" positioning tomorrow, while competitors still debugging their systems explain to frustrated patients why care is delayed.

Our recommendation: assign a marketing operations leader to participate in or monitor the testing initiative. This is not an IT project that marketing learns about after implementation. The workflow scenarios being tested directly impact patient experience at critical decision points, scheduling, referrals, specialty pharmacy, durable medical equipment. Marketing must understand where authorization creates friction, which patient segments are most affected, and how to communicate process improvements once systems are optimized.

Build authorization performance metrics into your patient experience dashboards now. Track authorization approval rates, processing times, and patient communication gaps by service line and payer. Establish baseline performance before electronic workflows go live, so you can measure and promote the improvements that result. When your authorization timelines drop from days to hours, that operational win becomes a marketing message: "Get the care you need, when you need it, without the wait."

Most importantly, recognize that authorization workflow excellence will become table stakes, not sustainable competitive advantage. Use that window to capture patient relationships, build referral network loyalty, and establish your brand promise around operational reliability. By the time competitors catch up on authorization workflows, you will have moved on to the next operational capability that translates to patient experience differentiation.

The Takeaway

Immediate Actions:

  • Designate a cross-functional team including marketing operations, IT, revenue cycle, and clinical leadership to evaluate participation in the ONC-CMS testing initiative. Register interest by November 20 if first-round participation makes strategic sense for your organization.
  • Audit current prior authorization performance across high-volume service lines. Establish baseline metrics for authorization processing time, approval rates, patient communication touchpoints, and abandonment rates between authorization request and completed service.
  • Map the patient experience of prior authorization for your top three service lines by volume. Identify every moment where patients wait for information, receive confusing communication, or must navigate administrative complexity. These friction points become your implementation priorities and your future marketing differentiators.

Sources

  1. [1] Office of the National Coordinator for Health Information Technology. "ONC and CMS Launch Industry Initiative Advancing Electronic Prior Authorization Testing." HealthIT.gov, 2026 healthit.gov

Frequently asked questions

What is the electronic prior authorization testing program by ONC and CMS?

The ONC and CMS opened registration for 10-12 week electronic prior authorization testing sprints with a November 20 deadline, recruiting payers, providers, EHR developers, and intermediaries to test systems in a virtual environment called FHIRplace. Testing will use HL7 FHIR Da Vinci implementation guides for Coverage Requirements Discovery, Documentation Templates and Rules, and Prior Authorization Support.

How can healthcare organizations benefit from participating in prior authorization testing?

Organizations participating in testing gain competitive intelligence about how trading partners (payers, EHR vendors, and intermediaries) are implementing electronic prior authorization before broader market deployment. This allows organizations to identify workflow gaps and prepare before widespread deployment, positioning them to capture market share.

What impact does prior authorization delay have on patient behavior?

Prior authorization delays currently cause patients to abandon care plans and switch providers, making electronic authorization a critical market share driver. When prior authorization delays treatment, patients abandon care plans, switch providers, or select competitors with smoother access pathways.

Who is coordinating the electronic prior authorization testing initiative?

MITRE leads coordination of participant matching and readiness discussions, while Drummond Group operates the FHIRplace virtual testing environment. Susan Hull at MITRE serves as the contact point for organizations interested in participating.